Sonic Healthcare (OTCMKTS:SKHHY) Upgraded to “Strong-Buy” at The Goldman Sachs Group

The Goldman Sachs Group upgraded shares of Sonic Healthcare (OTCMKTS:SKHHY) to a strong-buy rating in a research note released on Friday,Zacks.com reports.

Separately, Morgan Stanley set a $28.10 price target on shares of Sonic Healthcare in a research note on Wednesday, March 19th.

Sonic Healthcare Trading Down 3.8 %

OTCMKTS:SKHHY opened at $15.62 on Friday. The firm’s fifty day moving average price is $17.15 and its two-hundred day moving average price is $17.58. Sonic Healthcare has a one year low of $15.24 and a one year high of $20.59.

Sonic Healthcare Cuts Dividend

The company also recently declared a dividend, which was paid on Monday, March 31st. Investors of record on Thursday, March 6th were paid a $0.2816 dividend. The ex-dividend date of this dividend was Thursday, March 6th.

Sonic Healthcare Company Profile

Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry.